Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Harvard Bioscience, Inc. (NASDAQ: HBIO)
HBIO Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
0.80%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-7.70%
HBIO Stock Analysis
HBIO
PE Ratio:
HBIO
PEG Ratio:
Not Available
HBIO
Forward EPS Growth (12 month):
0.00%
HBIO
PS Ratio:
0.3
HBIO
PSG Ratio:
0.1
HBIO
Forward Revenue Growth (12 month):
6.30%
HBIO Articles
No data was found